Cellular Biomedicine Group (CBMG) Announces Publication Titled “Target cell killing effects of CD20 targeting chimeric antigen receptor T cells derived from the type II anti-CD20 antibody” in Conjunction with 2017 ASCO Annual Meeting

World News: . []

SHANGHAI China and CUPERTINO Calif May 19 2017 GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc NASDAQCBMG CBMG or the Company a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapie s for c...

More news and information about Cellular Biomedicine Group Inc.

Published By:

Globe Newswire: 13:28 GMT Friday 19th May 2017

Published: .

Search for other references to "cellular" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers